Figure 3 : Prevalence of increased serum cTn-T, increased plasma NT-proBNP and increased serum hs-CRP in
predialysis CKD patients having LVH (n= 72).
Sathi et al.Clinical Nephrology and Urology Science 2014 1:4DOI : 10.7243/2054-7161-1-4
Figure 3 : Prevalence of increased serum cTn-T, increased plasma NT-proBNP and increased serum hs-CRP in
predialysis CKD patients having LVH (n= 72).